1. Home
  2. KRRO vs PDSB Comparison

KRRO vs PDSB Comparison

Compare KRRO & PDSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Korro Bio Inc.

KRRO

Korro Bio Inc.

HOLD

Current Price

$9.37

Market Cap

58.6M

Sector

Health Care

ML Signal

HOLD

Logo PDS Biotechnology Corporation

PDSB

PDS Biotechnology Corporation

HOLD

Current Price

$1.11

Market Cap

49.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KRRO
PDSB
Founded
2014
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
58.6M
49.5M
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
KRRO
PDSB
Price
$9.37
$1.11
Analyst Decision
Buy
Strong Buy
Analyst Count
10
2
Target Price
$74.17
$9.00
AVG Volume (30 Days)
216.5K
494.0K
Earning Date
11-12-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$7,371,000.00
N/A
Revenue This Year
$144.83
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.20
$0.70
52 Week High
$55.89
$2.20

Technical Indicators

Market Signals
Indicator
KRRO
PDSB
Relative Strength Index (RSI) 48.58 68.41
Support Level $7.82 $0.76
Resistance Level $8.14 $0.93
Average True Range (ATR) 0.47 0.07
MACD 0.68 0.02
Stochastic Oscillator 97.15 89.69

Price Performance

Historical Comparison
KRRO
PDSB

About KRRO Korro Bio Inc.

Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability.

About PDSB PDS Biotechnology Corporation

PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.

Share on Social Networks: